GATWICK, England--(BUSINESS WIRE)--WOUNDCHEK™ Protease Status, the world’s first rapid, point of care test for the assessment of protease activity in chronic wounds, will be launched outside of the United States in December 2011. Developed to aid wound assessment and help clinicians target advanced wound care therapies more effectively, WOUNDCHEK™ Protease Status is the first product arising from the collaboration between Systagenix and Alere Scarborough, a subsidiary of Alere, a global leader in rapid point of care diagnostic testing.
